Expensive Retraction

A publisher bills authors $650 to retract a twice-published paper.

Written byBeth Marie Mole
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Flickr, Hey PaulAfter a graduate student and his advisor unknowingly submitted and published the same manuscript in two journals in 2009, they sought a retraction from one of the journals, the American Journal of Engineering and Applied Sciences, published by Science Publications, who told the researchers it will gladly pull the paper—for a fee. The publisher charged the authors a $650 “processing” fee for the retraction, provoking dismay from researchers and publication ethicists.

“Scholarly publishers have an obligation to maintain the integrity of the academic record and should immediately retract an article that is to be excluded from that record, without charge to anyone,” University of Colorado librarian Jeffrey Beall, who first reported the publication duplication and produces a list of predatory publishers, wrote in a blog post. Calling the fee unethical, Beall also cautioned that “this policy of charging disincentivises paper retractions—which are sometimes necessary.”

Ginny Barbour, chair of the Committee on Publication Ethics (COPE), echoed the sentiment in an interview with Retraction Watch, saying: “. . . you don’t want to put any financial barrier in the way of correcting the literature.” She added that she has never heard of such a billing policy before.

Though ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies